| Zinc deficiency dysregulates the synaptic ProSAP/Shank scaffold and might contribute to autism spectrum disorders S Grabrucker, L Jannetti, M Eckert, S Gaub, R Chhabra, S Pfaender, ... Brain 137 (1), 137-152, 2014 | 185 | 2014 |
| The PSD protein ProSAP2/Shank3 displays synapto-nuclear shuttling which is deregulated in a schizophrenia-associated mutation S Grabrucker, C Proepper, K Mangus, M Eckert, R Chhabra, ... Experimental neurology 253, 126-137, 2014 | 70 | 2014 |
| PTBP1 and PTBP2 repress nonconserved cryptic exons JP Ling, R Chhabra, JD Merran, PM Schaughency, SJ Wheelan, ... Cell reports 17 (1), 104-113, 2016 | 66 | 2016 |
| Insight on the fate of CNS-targeted nanoparticles. Part II: Intercellular neuronal cell-to-cell transport G Tosi, A Vilella, R Chhabra, MJ Schmeisser, TM Boeckers, B Ruozi, ... Journal of controlled release 177, 96-107, 2014 | 62 | 2014 |
| Nanoparticles as blood–brain barrier permeable CNS targeted drug delivery systems AM Grabrucker, R Chhabra, D Belletti, F Forni, MA Vandelli, B Ruozi, ... The Blood Brain Barrier (BBB), 71-89, 2014 | 57 | 2014 |
| Calpain cleavage and inactivation of the sodium calcium exchanger‐3 occur downstream of A β in A lzheimer's disease J Atherton, K Kurbatskaya, M Bondulich, CL Croft, CJ Garwood, ... Aging Cell 13 (1), 49-59, 2014 | 52 | 2014 |
| Depletion of TDP-43 decreases fibril and plaque β-amyloid and exacerbates neurodegeneration in an Alzheimer’s mouse model KD LaClair, A Donde, JP Ling, YH Jeong, R Chhabra, LJ Martin, ... Acta neuropathologica 132, 859-873, 2016 | 44 | 2016 |
| Emerging use of nanotechnology in the treatment of neurological disorders R Chhabra, G Tosi, A M Grabrucker Current pharmaceutical design 21 (22), 3111-3130, 2015 | 38 | 2015 |
| Loss of COMMD1 and copper overload disrupt zinc homeostasis and influence an autism-associated pathway at glutamatergic synapses T Baecker, K Mangus, S Pfaender, R Chhabra, TM Boeckers, ... BioMetals 27, 715-730, 2014 | 31 | 2014 |
| Characterization of lysosome-destabilizing DOPE/PLGA nanoparticles designed for cytoplasmic drug release R Chhabra, AM Grabrucker, P Veratti, D Belletti, TM Boeckers, ... International Journal of Pharmaceutics 471 (1-2), 349-357, 2014 | 24 | 2014 |
| Activity and circadian rhythm influence synaptic Shank3 protein levels in mice T Sarowar, R Chhabra, A Vilella, TM Boeckers, M Zoli, AM Grabrucker Journal of Neurochemistry 138 (6), 887-895, 2016 | 22 | 2016 |
| Application of polymeric nanoparticles for CNS targeted zinc delivery in vivo R Chhabra, B Ruozi, A Vilella, D Belletti, K Mangus, S Pfaender, ... CNS & Neurological Disorders-Drug Targets (Formerly Current Drug Targets-CNS …, 2015 | 17 | 2015 |
| The blood brain barrier (BBB) A Grabrucker, R Chhabra, D Belletti, F Forni, M Vandelli, B Ruozi, G Tosi Topics in medicinal chemistry 71, 89, 2014 | 5 | 2014 |
| Delivery of Bioactive Substances Into the CNS Using Nanomedical Approaches for the Treatment of Synaptopathies R Chhabra Ulm University, 2015 | | 2015 |
